🔗 Share this article

Treasury head Reeves has stated she is planning "targeted action to tackle household expense challenges" in the upcoming financial statement.

In comments to the BBC, she stated that reducing price rises is a joint duty of both the administration and the Bank of England.

The United Kingdom's price growth is forecast to be the most elevated among the Group of Seven developed nations this year and the following year.

Possible Energy Bill Measures

It is understood the government could intervene to lower utility costs, such as by slashing the current 5% level of value-added tax charged on energy.

A further possibility is to reduce some of the regulatory levies currently included in bills.

Budgetary Limitations and Analyst Expectations

The government will receive the latest assessment from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much space there is for these actions.

The view from most experts is that Reeves will have to declare tax rises or expenditure reductions in order to adhere to her voluntary debt limits.

Earlier on the same day, calculations showed there was a twenty-two billion pound deficit for the chancellor to fill, which is at the more modest range of projections.

"There's a shared task between the Bank of England and the government to further reduce some of the causes of price increases," Reeves informed reporters in Washington, at the annual meetings of the IMF and global financial institution.

Tax Commitments and International Issues

While a great deal of the focus has been on expected tax rises, the Treasury chief said the most recent data from the OBR had not changed her commitment to manifesto promises not to increase tax levels on income tax, sales tax or social security contributions.

She blamed an "uncertain world" with growing international and trade tensions for the fiscal revenue measures, likely to be directed on those "most able to pay."

International Trade Tensions

Referring to worries about the United Kingdom's trade ties with the Asian nation she said: "The UK's national security invariably are paramount."

Last week's statement by China to strengthen trade restrictions on rare earths and other materials that are crucial for advanced tech production led American leader the US President to suggest an further 100% tariff on imports from China, increasing the possibility of an all-out commercial conflict between the two economic giants.

The American finance chief called the Chinese action "commercial pressure" and "a global supply chain power grab."

Questioned on considering the American proposal to participate in its conflict with China, Reeves said she was "deeply worried" by China's measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "damaging for the global economy and generates additional challenges."

"I believe there are fields where we need to challenge Chinese policies, but there are also significant prospects to trade with China's economy, including financial services and other areas of the economic system. We've got to get that equilibrium correct."

The chancellor also affirmed she was cooperating with G7 counterparts "on our own critical minerals plan, so that we are less reliant."

NHS Drug Costs and Investment

Reeves also admitted that the cost the National Health Service spends on medicines could increase as a consequence of current negotiations with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either halting or abandoning projects in the UK, with some attributing the modest returns they are getting.

Last month, the government science advisor said the cost the NHS spends on drugs would need to go up to stop companies and pharmaceutical investment departing from the UK.

Reeves informed the BBC: "We have seen because of the cost structure, that clinical trials, innovative medicines have not been provided in the UK in the extent that they are in other European countries."

"The objective is to guarantee that patients getting treatment from the NHS are able to access the finest life-saving drugs in the globe. And so we are looking at these issues, and... aiming to attract additional capital into the UK."